Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Perrigo Company    PRGO

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2014 4 011 M
EBIT 2014 944 M
Net income 2014 422 M
Debt 2014 2 404 M
Yield 2014 0,23%
Sales 2015 5 534 M
EBIT 2015 1 516 M
Net income 2015 471 M
Debt 2015 3 965 M
Yield 2015 0,23%
PER 2014 63,81
PER 2015 69,97
EV / Sales 2014 7,27x
EV / Sales 2015 5,55x
Capitalization 26 765 M
More Financials
Company
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company operates its business through following segments: Consumer Healthcare, Nutritionals,... 
Sector
Pharmaceuticals
Calendar
10/29Earnings Release
More about the company
Surperformance© ratings of Perrigo Company
Trading Rating : Investor Rating :
More Ratings
Latest news on PERRIGO COMPANY
08/29 PERRIGO : mylan perrigo shareholder vote 8-28 pq jsm
08/28 PERRIGO : BRIEF: Mylan shareholders approve Perrigo takeover bid
08/28 PERRIGO : Mylan shareholders approve $34 billion hostile takeover bid for Perrig..
08/28 PERRIGO : Mylan shareholders approve pursuit of Perrigo
08/28DJMylan's Holders Approve Perrigo Purchase
08/28 PERRIGO : Majority Mylan shareholders vote for Perrigo takeover bid
08/27 PERRIGO : Stichting foundation not attending Mylan meeting
08/26 PERRIGO : Mylan leaders spar as vote looms
More news
Sector news : Pharmaceuticals - NEC
01:16a NOVARTIS : receives EU approval for Tafinlar® and Mekinist®, first combination a..
08/31 BRIEF : United Airlines to enter S&P 500, replacing Hospira
08/31 Chipotle sued over GMO-free menu claims
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions